Long-term functional outcome after hyperthermic isolated limb perfusion (HILP)

By Knorr C.   Melling N.   Goehl J.   Drachsler T.   Hohenberger W.   Meyer T.  

International Journal of Hyperthermia, Vol. 24, Iss. 5, 2008-01 ,pp. : 409-414

Informa Healthcare

Access to resources Recommend Favorite

Long-term follow-up of 163 consecutive patients treated with isolated limb perfusion for in-transit metastases of malignant melanoma

By Olofsson Roger   Mattsson Jan   Lindnér Per  

International Journal of Hyperthermia, Vol. 29, Iss. 6, 2013-09 ,pp. : 551-557

Informa Healthcare

Access to resources Recommend Favorite

Toxicities associated with hyperthermic isolated limb perfusion and isolated limb infusion in the treatment of melanoma and sarcoma

By Moller Mecker   Lewis James   Dessureault Sophie   Zager Jonathan  

International Journal of Hyperthermia, Vol. 24, Iss. 3, 2008-01 ,pp. : 275-289

Informa Healthcare

Access to resources Recommend Favorite

Hyperthermic isolated limb perfusion with TNFalpha and cisplatin in the treatment of osteosarcoma of the extremities: a feasibility study in healthy dogs

By Ginkel Robert J. Van   Berlo Charles L. H. Van   Baas Peter C.   Koops Heimen Schraffordt   Stuling Ries Van Groningen B.   Elstrodt Jan   Hoekstra1 Harald J.  

Sarcoma, Vol. 3, Iss. 2, 1999-09 ,pp. : 89-94

Informa Healthcare

Access to resources Recommend Favorite

Long-Term Results of Melphalan-Based Isolated Limb Perfusion With or Without Low-Dose TNF for In-Transit Melanoma Metastases

By Rossi Carlo  

Annals of Surgical Oncology, Vol. 17, Iss. 11, 2010-11 ,pp. : 3000-3007

Springer Publishing Company

Access to resources Recommend Favorite